Advertisement

Are there enough radiation oncologists to lead the new Spanish radiotherapy?

  • A. RodríguezEmail author
  • M. Arenas
  • P. C. Lara
  • J. López-Torrecilla
  • M. Algara
  • A. Conde
  • H. Pérez-Montero
  • J. L. Muñoz
  • P. Peleteiro
  • M. J. Pérez-Calatayud
  • J. Contreras
  • C. Ferrer
  • The Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group
Research Article

Abstract

Aim

Radiation oncology services in Spain are undergoing a process of technical modernization, but—in a context of increasing demand by an ageing population—it is unclear whether there are enough radiation oncologists to staff the newly equipped units. This study aims to assess the number of specialists working in radiation oncology services in Spain relative to current and future needs.

Materials and methods

In the second half of 2017, the Commission on Infrastructures of the Spanish Society for Radiation Oncology (SEOR) sent a questionnaire on radiation oncology staff to the heads of all 122 public (n = 76, 62%) and private (n = 46, 38%) radiation oncology services in Spain. Data collected were the number of professionals, their position, and their year of birth for specialists and residents in each service. In the descriptive analysis, for continuous variables we calculated means, standard deviations and ranges for each Spanish region and work post. For qualitative variables, we constructed frequency tables. All analyses were performed with R statistical software, version 3.5.1.

Results

The survey response rate was 100% among service heads across all 122 centers. The total number of radiation oncologists working in these centers is 721, or 15.4 per million population, with considerable variations between regions. Given the national recommendations to have 20 radiation oncologists per million population, there is currently a deficit of 204 specialists. If the 163 upcoming retirements are also taken into account, there will be 367 fewer radiation oncologists than required to meet the 25% increase in indications for radiotherapy projected for 2025.

Conclusions

The classic model for calculating staff needs based on the number of treatments is outdated, and recommendations should be revised to reflect the current reality. A new model should integrate the most complex technological advances and emerging plans in radiotherapy, without neglecting the other activities carried out in radiation oncology services that are not directly linked to patient care.

Keywords

Radiotherapy staffing needs Radiation oncologists Spain 

Notes

Acknowledgements

On behalf of the Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group: Dra Mª José Ortiz del Hospital Universitario Virgen del Rocio (Sevilla). Dr José Expósito del Hospital Universitario Virgen de las Nieves (Granada). Dra Amalia Palacios del Hospital Universitario Reina Sofía (Córdoba). Dr Ismael Herruzo del Hospital Regional Universitario Carlos Haya (Málaga). Dr José Antonio Medina del Hospital Universitario Virgen de la Victoria (Málaga). Dr Miguel Martinez del Complejo Hospitalario de Jaén (Jaén). Dra Eloisa Bayo del Hospital Juan Ramón Jiménez (Huelva) y Hospital Virgen Macarena (Sevilla). Dr Javier Jaén del Hospital Puerta del Mar (Cádiz). Dr Francisco José Peracaula del Hospital Punta Europa (Cádiz). Dra Carolina Pérez del Complejo Hospitalario Torrecárdenas (Almería). Dra Mª Isabel Ramos de Clínica Infanta Luisa (Sevilla). Dr José Antonio González del Instituto Oncológico Cartuja (Sevilla). Dr José Begara de Clínica Xanit Limonar (Málaga). Dra Cristina Nuño de Clínica Xanit Benalmádena (Málaga). Dra Ana Belén Bezares de Clínica Radón Algeciras (Cádiz). Dra Ana Serradilla de Clínica Radón Jerez de la Frontera (Cádiz). Dr Antonio Lazo de Oncosur San Juan de Dios (Córdoba). Dr Martin Tejedor del Hospital Universitario Miguel Servet (Zaragoza). Dra Lucía Méndez del IMOMA (Oviedo). Dr Germán Juan de la Fundación Hospital de Jove (Asturias). Dr Luis Olay del Hospital Universitario Central de Asturias. Dr José Pardo del Hospital Universitario Son Espases (Palma de Mallorca). Dr Alberto Noé del Hospital Can Misses (Ibiza). Dr Francisco Mestre de Policlínica Miramar (Palma de Mallorca). Dr Claudio Otón del Hospital Universitario de Canarias (Tenerife). Dr Claudio Fuentes del Hospital Universitario Nuestra Señora de la Candelaria (Tenerife). Dr Pedro Prada del Hospital Universitario Marqués de Valdecilla (Santander). Dr Leopoldo Pérez de Clínica Mompía (Santander). Dra Eva Lozano del Hospital General de Ciudad Real. Dra Mª Victoria Villas del Complejo Hospitalario Universitario (Albacete). Dra Juana Tripero del Grupo GenesisCare (Guadalajara). Dra Rosabel Lobo del Grupo GenesisCare (Toledo). Dr Manuel Muñoz del Grupo GenesisCare (Toledo). Dr José Luis Tisaire del Hospital Universitario de Jerez de la Frontera (Cádiz). Dr Jesús Fernández del IVO (Cuenca). Dra Mercedes Teijeira del Hospital Universitario (Burgos). Dr José Reyes Rodríguez del Complejo Asistencial de León. Dr Luis Pérez-Romasanta del Hospital Clínico Universitario (Salamanca). Dr Francisco López del Hospital Clínico Universitario (Valladolid). Dr Daniel Rodríguez del Hospital Clínico Universitario (Valladolid). Dra Amelia Ceballos del Complejo Asistencial de Zamora. Dra Rocío Cantalapiedra del Hospital Campo Grande (Valladolid). Dr Albert Biete del Hospital Clinic Universitario (Barcelona). Dr Jordi Craven del Hospital de la Creu i Sant Pau y Clínica Corachan (Barcelona). Dr Agustí Pedro del Hospital PLATÓ (Barcelona). Dr Jordi Giralt del Hospital Valle-Hebrón (Barcelona). Dr Ferrán Guedea del Hospital Duran i Reinals ICO (Barcelona). Dr Salvador Villá del Hospital de Badalona (Barcelona). Dr Josep M Solé del Hospital General de Cataluña (Barcelona). Dra Arantxa Eraso del Hospital Universitario de Gerona. Dr José Antonio Carceller del Hospital Universitario Arnau Vilanova (Lérida). Dr Benjamín Guix del IMOR (Barcelona). Dr Ramón Miralbell del centro Médico Teknon (Barcelona). Dr Joan Casals del Hospital Quirón (Barcelona). Dr Pedro González del Hospital de Mérida (Badajoz). Dra Mª Isabel Duarte del Hospital Virgen del Puerto (Cáceres). Dr Juan Pablo Jerez de la Clínica San Miguel (Cáceres). Dr Alfonso Mariño del Centro Oncológico de Galicia (La Coruña). Dr Antonio Gómez-Caamaño del Hospital Universitario de Santiago de Compostela (La Coruña). Dr Victor Muñoz del Hospital do Mexoeiro de Vigo (Pontevedra). Dra Mª Dolores López del Complejo Hospitalario de Orense. Dr Luis Zugazabeitia de POVISA Vigo (Pontevedra). Dra Laura Torrado-Moya del Hospital Universitario de Lugo. Dr Gustavo Ossola del Hospital de San Pedro (Logroño). Dra Rosa Mª Morera del Hospital Universitario de la Paz (Madrid). Dra Mª Teresa Murillo del Hospital Universitario de la Princesa (Madrid). Dra Sonsoles Sancho del Hospital Universitario Ramón y Cajal (Madrid). Dr José Pérez-Regadera del Hospital Universitario Doce de Octubre (Madrid). Dr Miguel Angel Lozano del Hospital Universitario Gregorio Marañón (Madrid). Dr Gonzalo Vázquez del Hospital Clínico San Carlos (Madrid). Dra Escarlata López de la Fundación Jiménez Díaz (Madrid). Dra Cristina de la Fuente del Hospital Universitario Puerta de Hierro (Madrid). Dra Pilar Samper del Hospital Rey Juan Carlos (Madrid). Dra Blanca Ludeña del Hospital Universitario de Fuenlabrada (Madrid). Dr Juan de Dios Sáez del Hospital Central de la Defensa Gómez-Ulla (Madrid). Dr Ignacio Azinovic del Grupo Génesis Care. Dra Carmen Rubio del CIOCC (Madrid). Dra Elia del Cerro del Hospital Quirón (Madrid). Dra Natalia Carballo del MD Anderson (Madrid). Dra Amalia Sotoca-Ruiz del Hospital Ruber Internacional. Dr Ramón García del Hospital Universitario Virgen de la Arrixaca (Murcia). Dr Juan Salinas del Hospital General Universitario de Cartagena (Murcia). Dra Adriana Fondevilla del Instituto Oncológico del Sudeste (Murcia). Dr Rafael Martínez-Monge de la Clínica Universitaria de Navarra (Pamplona). Dr Enrique Martinez del Complejo Hospitalario de Navarra (Pamplona). Dr Avelino Alia del Hospital de Txagorritxu (Vitoria). Dr Juan Pablo Ciria del Hospital Universitario de Donostia (San Sebastián). Dr Jesús Rosa del Instituto Oncológico de San Sebastián. Dr Pedro Bilbao del Hospital Universitario de Cruces (Bilbao). Dr Juan Carlos Martín del Hospital Universitario de Basurto (Bilbao). Dr Francisco Casquero del Hospital Quirón (Bilbao). Dr Leo Arribas del Instituto Valenciano de Oncología (Valencia). Dr Alejandro Tormo del Hospital Universitario de la Fe (Valencia). Dr Eduardo Ferrer del Hospital Clínico (Valencia). Dr Luis Larrea de la Clínica Virgen del Consuelo (Valencia). Dr Miguel Soler del Hospital Universitario de la Ribera (Valencia). Dr Enrique García del Hospital Universitario de Elche (Alicante). Dr Pablo Soler del Hospital IMED Elche (Alicante). Dr Manuel Santos del Hospital de Benidorm (Alicante). Dr Gabriel Vázquez del Hospital Universitario San Juan (Alicante). Dra Rosa Mª Cañón del Hospital Quirón Torrevieja (Alicante). Dr Antonio Miró del Hospital Vithas Perpetuo Socorro (Alicante).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Rodríguez A, Borràs JM, López-Torrecilla JL, Algara M, Palacios-Eito A, Gómez-Caamaño A, et al. Demand for radiotherapy in Spain. Clin Transl Oncol. 2017;19(2):204–10.CrossRefGoogle Scholar
  2. 2.
    Fernández JL, Parapar C. Ruiz M El envejecimiento de la población, Lychnos 2, Cuadernos de la Fundación general CSIC. 2015. ISSN: 2174-5102. http://www.fgcsic.es/lychnos/es_es/articulos/envejecimiento_poblacion. Accessed 6 Dec 2018.
  3. 3.
    Borràs JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, et al. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol. 2016;119(1):5–11.CrossRefGoogle Scholar
  4. 4.
    Rodríguez A, Algara M, Monge D, López-Torrecilla J, Caballero F, Morera R, et al. Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020. Clin Trans Oncol. 2018;20(3):402–10.CrossRefGoogle Scholar
  5. 5.
    Arenas M, Sabater S, Gascón M, Henriquez I, Bueno MJ, Rius A, et al. Quality assurance in radiotherapy: analysis of the causes of not starting on early radiotherapy withdrawal. Radiat Oncol. 2014;4(9):260.CrossRefGoogle Scholar
  6. 6.
    Lara PC, Rodriguez A, Ferrer C, Aristu JJ, Prada PJ, Muñoz J, et al. Rescuing Spanish radiation therapy: the role of leadership and opportunity. Int J Radiat Oncol Biol Phys. 2018;100(2):292–6.CrossRefGoogle Scholar
  7. 7.
    Amalia PE, Sonia GC, Ismael HC, José ASC, María EC, María M-P. Análisis de situación y estrategias de futuro. Recursos Humanos en Oncología Radioterápica. Cap 4.1 en Libro Blanco SEOR XXI. 2010;53–63. ISBN 978-84-7714-344-4.Google Scholar
  8. 8.
    Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.CrossRefGoogle Scholar
  9. 9.
    Palacios A, Espinosa M, Mañas A, de las Heras M. Radiation oncology: future needs and equipment. Current situation in Spain. Clin Trans Oncol. 2008;10:478–85.CrossRefGoogle Scholar
  10. 10.
    Bentzen SM, Heeren G, Cottier B, Slotman B, Glimelius B, Lievens Y, et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol. 2005;75(3):355–65.CrossRefGoogle Scholar
  11. 11.
    Slotman BJ, Cottier B, Bentzen SM, Heeren G, Lievens Y, Van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1. Radiother Oncol. 2005;75(3):349–54.CrossRefGoogle Scholar
  12. 12.
    Grau C, Dofourney N, Malicki J, Dunscombe P, Borras JM, Coffey M, et al. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112:155–64.CrossRefGoogle Scholar
  13. 13.
    Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, et al. Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112:178–86.CrossRefGoogle Scholar
  14. 14.
    Rosenblatt E, Izewska J, Anacak Y, Pynda Y, Scaillet P, Boniol M. Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol. 2013;14(2):e79–86.CrossRefGoogle Scholar
  15. 15.
    Arenas M, Gomez D, Sabater S, Rovirosa A, Biete A, Colomer J. Decentralisation of radiation therapy. Is it posible and beneficial to patients? Experience of the first 5 years of a satellite radiotherapy unit in the province of Tarragona, Spain. Rep Pract Oncol Radiother. 2014;20(2):141–4.CrossRefGoogle Scholar
  16. 16.
    Flynn DF, Hussey DH. Review of the manpower issue in radiation oncology. Int J Radiat Oncol Biol Phys. 1992;24(5):909–12.CrossRefGoogle Scholar
  17. 17.
    Enrici RM, De Sanctis V. Radiation oncology in Italy: the past, the present and the future. Int J Radiat Oncol Biol Phys. 2015;91(4):692–6.CrossRefGoogle Scholar
  18. 18.
    Prades J, Algara M, Espinàs JA, Farrús B, Arenas M, Reyes V, et al. Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: a mixed-methods study. Radiother Oncol. 2017;123(1):22–8.CrossRefGoogle Scholar
  19. 19.
    Datta NR, Samiei M, Bodis S. Radiotherapy infrastructure and human resources in Europe—present status and its implications for 2020. Eur J Can. 2014;50:2735–43.CrossRefGoogle Scholar
  20. 20.
    Pan Hubert Y, Haffty Bruce G, Falit Benjamin P, Buchholz Thomas A, Wilson Lynn D, Hahn Stephen M, et al. Supply and demand for radiation oncology in the United States: updated projections for 2015 to 2025. Int J Radiat Oncol Biol Phys. 2016;96(3):493–500.CrossRefGoogle Scholar
  21. 21.
    Stuckless T, Milosevic M, de Metz C, Parliament M, Tompkins B, Brundage M. Managing a national radiation oncologist workforce: a workforce planning model. Radiother Oncol. 2012;103(1):123–9.CrossRefGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2019

Authors and Affiliations

  • A. Rodríguez
    • 1
    Email author
  • M. Arenas
    • 2
    • 3
  • P. C. Lara
    • 4
    • 5
  • J. López-Torrecilla
    • 6
  • M. Algara
    • 7
    • 8
  • A. Conde
    • 9
  • H. Pérez-Montero
    • 10
  • J. L. Muñoz
    • 11
  • P. Peleteiro
    • 12
  • M. J. Pérez-Calatayud
    • 13
  • J. Contreras
    • 14
  • C. Ferrer
    • 15
  • The Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group
  1. 1.Department of Radiation OncologyHospital Ruber InternacionalMadridSpain
  2. 2.Department of Radiation OncologyHospital Universitari Sant Joan de ReusReusSpain
  3. 3.Universidad Rovira i VirgiliReusSpain
  4. 4.Department of Radiation OncologyHospital, Universitario San RoqueLas PalmasSpain
  5. 5.Universidad Fernando Pessoa CanariasLas PalmasSpain
  6. 6.Department of Radiation OncologyERESA Hospital General UniversitarioValenciaSpain
  7. 7.Department of Radiation OncologyHospital del MarBarcelonaSpain
  8. 8.Universidad Autónoma de BarcelonaBellaterraSpain
  9. 9.Department of Radiation OncologyHospital, Universitario y Politécnico La FeValenciaSpain
  10. 10.Instituto Catalán de OncologíaBarcelonaSpain
  11. 11.Department of Radiation OncologyHospital Universitario de BadajozBadajozSpain
  12. 12.Hospital Clinico Universitario de Santiago de CompostelaLa CoruñaSpain
  13. 13.Department of Radiation OncologyHospital, Universitario y Politécnico La FeValenciaSpain
  14. 14.Department of Radiation OncologyHospital Regional de MálagaMalagaSpain
  15. 15.Department of Radiation OncologyConsorcio Hospitalario Provincial de CastellónCastellónSpain

Personalised recommendations